TELO · Categories · Form 4

TELO - SEC Form 4 insider transactions

Telomir Pharmaceuticals Inc. (TELO) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for TELO

• 23d
  SEC Form 4 filed by CEO and Chairman Aminov Erez

  4 - Telomir Pharmaceuticals, Inc. (0001971532) (Issuer)
• 23d
  SEC Form 4 filed by Director Whalen Matthew Pratt

  4 - Telomir Pharmaceuticals, Inc. (0001971532) (Issuer)
• 23d
  SEC Form 4 filed by Director Macpherson Edward Clouston

  4 - Telomir Pharmaceuticals, Inc. (0001971532) (Issuer)
• 23d
  SEC Form 4 filed by Director Del Giudice Matthew Paul

  4 - Telomir Pharmaceuticals, Inc. (0001971532) (Issuer)
• 52d
  CEO and Chairman Aminov Erez acquired $10,028,003 worth of shares (7,319,710 units at $1.37) (SEC Form 4)

  4 - Telomir Pharmaceuticals, Inc. (0001971532) (Issuer)
• 380d
  SEC Form 4 filed by CEO and Chairman Aminov Erez

  4 - Telomir Pharmaceuticals, Inc. (0001971532) (Issuer)
• 566d
  SEC Form 4 filed by Large owner Bay Shore Trust

  4 - Telomir Pharmaceuticals, Inc. (0001971532) (Issuer)
• 649d
  SEC Form 4 filed by Chief Financial Officer Yanez Michelle

  4 - Telomir Pharmaceuticals, Inc. (0001971532) (Issuer)
• 655d
  SEC Form 4 filed by Director Macpherson Edward Clouston

  4 - Telomir Pharmaceuticals, Inc. (0001971532) (Issuer)
• 655d
  SEC Form 4 filed by Director Jerman Michael Allen

  4 - Telomir Pharmaceuticals, Inc. (0001971532) (Issuer)
• 655d
  SEC Form 4 filed by Director Del Giudice Matthew Paul

  4 - Telomir Pharmaceuticals, Inc. (0001971532) (Issuer)
• 655d
  SEC Form 4 filed by CEO & Chairman Aminov Erez

  4 - Telomir Pharmaceuticals, Inc. (0001971532) (Issuer)
• 655d
  SEC Form 4 filed by Director Whalen Matthew Pratt

  4 - Telomir Pharmaceuticals, Inc. (0001971532) (Issuer)

Other TELO categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends